Contents:
Document Title
Anticipatory Medication Guidelines
Document Date
March 2024
Document Purpose and Intended Audience
The aim of these guidelines is to ensure staff are informed and and Intended able to manage patients symptoms at the end of life Audience These guidelines are suitable for use in both primary community care and in the in-patient setting
Author
Dr Anna Lock, Palliative Medicine Consultant, Sandwell and West Birmingham Hospitals NHS Trust
Michelle Aslett, Specialist Palliative Care Pharmacist, Marie Curie
Consultation Process
Reviewed by SPAGG and ratified
Monitoring
This will be audited and reviewed every 3 years
Review Date
(must be within three years)
April 2027
Approval Signatures:
SPAGG chair
Dr Jon Tomas
SPAGG secretary
Dr Alice Gray
Date Approved by SPAGG: March 2024
Date submitted to Area Prescribing Committee: N/A
Version History
Version 1
Date
March 2024
Summary of change/ process
Three separate guidelines unified
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.